Thyroid cancer
Conditions
Interventions
1:All selected patients with sinistral thyroxine tablet (brand name: excellent armour, Germany Merck pharmaceutical co., LTD., production, 50 mu g/piece) inhibition of foundation treatment, collect pa
Sponsors
The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with thyroid cancer, who were diagnosed with clinical diagnosis, were treated with thyroid surgery and treated with iodine-131 after surgery.
Exclusion criteria
Exclusion criteria: Those who are pregnant, nursing women, and liver function; A combination of severe primary diseases such as cardiovascular, liver, kidney and hematopoietic systems, and psychiatric patients; A merger of other tumours; Other drugs, glucocorticoid and other immunosuppressant agents, as well as other clinical trials for other drugs in March, were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The thyroid gland colour to exceed;Thyroid function: chemiluminescence to determine serum FT3, FT4, TSH, TGAb, TPOAb, TRAb.;Thyroid globulin (TG) measurement;Mental - mental - sentiment analysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood routine, urine routine, liver and kidney function, blood sugar, blood lipids, ECG; | — |
Countries
China
Contacts
Public ContactYan Shuxun
The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine
Outcome results
None listed